SCHEMBL1674893

SCHEMBL1674893

O=C1CC=Cc2ccc3oc4c5ccccc5ccc4c3c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ARSA P15289 1/20 0.41
CDC25A P30304 1/20 0.41
CDC25C P30307 1/20 0.41
KMT2A Q03164 2/20 0.39
CES1 P23141 1/20 0.38
IKBKB O14920 1/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
HTT P42858 3/20 0.38
ESR1 P03372 1/20 0.38
POLB P06746 1/20 0.38
CYP1B1 Q16678 4/20 0.37
PRKDC P78527 4/20 0.37
HPGD P15428 3/20 0.37
MAPT P10636 3/20 0.37
CYP1A1 P04798 3/20 0.37
ABCG2 Q9UNQ0 3/20 0.37
HSD17B10 Q99714 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16538009 0.82 MAOA (0.43) TDP1L3MBTL1CDC25ACDC25CKMT2A
SCHEMBL7577681 0.79 CES1 (0.61) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL8791995 0.79 CES1 (0.54) TDP1L3MBTL1KMT2ACES1KDM4E
SCHEMBL29457692 0.78 ALDH1A1 (0.49) TDP1L3MBTL1KMT2ACES1ALDH1A1
SCHEMBL442615 0.72 L3MBTL1 (0.50) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL29612101 0.72 L3MBTL1 (0.50) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL13935799 0.69 L3MBTL1 (0.47) TDP1L3MBTL1ARSACDC25ACDC25C
SCHEMBL261907 0.69 CES1 (0.39) KMT2ACES1KDM4EALDH1A1CYP1B1
SCHEMBL457599 0.68 TYMS (0.37) TDP1L3MBTL1KMT2ACES1KDM4E
SCHEMBL12764548 0.68 MAOA (0.61) TDP1L3MBTL1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1521815-B1 COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING BASF SE (DE) 2008-07-16 EP claimed
US-7252785-B2 Composition of a radiation-absorbing tert-alkylphenoxy-substituted polycyclic ccmpound and a curable IR-reflecting component of achiral nematic polymerizable monomer, a chiral polymerizable monomer, a cholesteric polymerizable monomer, and a cholesteric polymer in a polymerizable diluent BASF AKTIENGESELLSCHAFT (DE) 2007-08-07 US claimed
US-20050221091-A1 Composition for producing a thermal insulation coating BASF AKTIENGESELLSCHAFT (DE) 2005-10-06 US claimed
EP-1373272-B1 TERT. ALKYLPHENOXY SUBSTITUTED POLYCYCLIC COMPOUNDS BASF AG (DE) 2005-06-29 EP claimed
EP-1521815-A2 COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING BASF AKTIENGESELLSCHAFT (DE) 2005-04-13 EP claimed
US-20040049030-A1 Tert alkylphenoxy substituted polycyclic compounds BASF SE (DE) 2004-03-11 US claimed
WO-2004005427-A2 COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING BASF AKTIENGESELLSCHAFT (DE) 2004-01-15 WO claimed
US-11999865-B2 UV curable composition for use in 3D printing BASF SE (DE) 2024-06-04 US disclosed
EP-3856856-B1 UV CURABLE COMPOSITION FOR USE IN 3D PRINTING BASF SE (DE) 2024-05-29 EP disclosed
EP-3911687-B1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2023-11-01 EP disclosed
EP-4017938-A1 A PROCESS FOR THE PRODUCTION OF FINGERPRINT TEXTURE FREE LIQUID CRYSTAL FILMS BASF SE (DE) 2022-06-29 EP disclosed
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2022-03-03 US disclosed
US-20220033678-A1 PHOTOCURABLE COMPOSITION FOR USE IN 3D PRINTING BASF SE (DE) 2022-02-03 US disclosed
US-20050221091-A1 Composition for producing a thermal insulation coating BASF AKTIENGESELLSCHAFT (DE) 2005-10-06 US disclosed
EP-1373272-B1 TERT. ALKYLPHENOXY SUBSTITUTED POLYCYCLIC COMPOUNDS BASF AG (DE) 2005-06-29 EP disclosed
EP-1521815-A2 COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING BASF AKTIENGESELLSCHAFT (DE) 2005-04-13 EP disclosed
US-20040049030-A1 Tert alkylphenoxy substituted polycyclic compounds BASF SE (DE) 2004-03-11 US disclosed
WO-2004005427-A2 COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING BASF AKTIENGESELLSCHAFT (DE) 2004-01-15 WO disclosed
EP-1373272-A2 TERT. ALKYLPHENOXY SUBSTITUTED POLYCYCLIC COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2004-01-02 EP disclosed
WO-2002076988-A2 TERT. ALKYLPHENOXY SUBSTITUTED POLYCYCLIC COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2002-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING LIMK1, LIMA1, LIMK2 TDP1 1394/4885L3MBTL1 589/4885ARSA 693/4885
US-20040049030-A1 Tert alkylphenoxy substituted polycyclic compounds NR3C1, NR1H4, NR5A1 TDP1 3205/4885L3MBTL1 2486/4885ARSA 2067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.